Lv1
56 积分 2026-03-12 加入
New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway
2天前
已完结
Safety and efficacy of subcutaneous injection with HMI-115 versus placebo in endometriosis-associated pain in premenopausal women: a multicentre, double-blind, randomised, proof-of-concept phase 2 trial
22天前
已完结
Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial
1个月前
已关闭
De novo design of miniproteins targeting GPCRs
1个月前
已完结
Epidemiology of cardiovascular–kidney–metabolic syndrome
1个月前
已完结
The evolving landscape of obesity pharmacotherapy
1个月前
已完结
A unifying model of stem cell dynamics explains age-related methylation patterns across mammals
1个月前
已完结
Development of small-molecule PCSK9 inhibitors for the treatment of hypercholesterolemia
1个月前
已完结
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
2个月前
已完结
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
2个月前
已完结
皖公网安备34019202002308
